Pro Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.00 Cr
as on 16-11-2024
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 14.38 Cr
as on 16-11-2024
- Revenue 41.51%
(FY 2023)
- Profit 3238.34%
(FY 2023)
- Ebitda 11.25%
(FY 2023)
- Net Worth 0.85%
(FY 2023)
- Total Assets 25.49%
(FY 2023)
About Pro Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹14.00 Cr. The company has closed loans amounting to ₹14.38 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anup Doshi and Sandeep Bhargava serve as directors at the Company.
- CIN/LLPIN
U24231MP2005PTC017345
- Company No.
017345
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Pro Laboratories Private Limited offer?
Pro Laboratories Private Limited offers a wide range of products and services, including Antihistamines, Diphenhydramine Pharmaceutical Syrup, Aceclofenac Tablet, Aceclofenac Paracetamol Tablet, Injectable Products, Dry Injections.
Who are the key members and board of directors at Pro Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anup Doshi  | Director | 15-Feb-2005 | Current |
| Sandeep Bhargava | Director | 04-Jun-2021 | Current |
Financial Performance of Pro Laboratories.
Pro Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.51% increase. The company also saw a substantial improvement in profitability, with a 3238.34% increase in profit. The company's net worth moved up by a moderate rise of 0.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pro Laboratories?
In 2023, Pro Laboratories had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Jun 2023 | ₹14.00 Cr | Open |
Axis Bank Limited Creation Date: 07 Feb 2013 | ₹4.00 Cr | Satisfied |
Bank Of Baroda Creation Date: 28 Nov 2005 | ₹10.38 Cr | Satisfied |
How Many Employees Work at Pro Laboratories?
Pro Laboratories has a workforce of 2 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pro Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pro Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
